- RecruitingPHASE2
Methods of T Cell Depletion Trial (MoTD)
This study compares different ways to prevent a complication called GvHD after stem cell transplants for various blood cancers. It's looking for the best treatment plan to help patients recover well, using common medicines like Thymoglobulin, Cyclophosphamide, Cyclosporine, Sirolimus, and Mycophenolate Mofetil.
For: Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Chronic Myelomonocytic LeukemiaUnited Kingdom - RecruitingPHASE3
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor
This study compares two medicines, Grafalon and Thymoglobulin, used to prevent a common complication called GVHD after a stem cell transplant for blood cancers. It focuses on older patients (age 50-70) with AML or MDS, finding the safest and most effective treatment.
For: GVHDFrance